# generate_tests\Test mAB\IgG1-K-002.txt
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Trypsin - 50%
GLEWVSAITWNSGHIDYADSVEGR
AEDTAVYYCAK
VSYLSTASSLDYWGQGTLVTVSSASTK
GPSVFPLAPSSK
THTCPPCPAPELLGGPSVFLFPPKPK
DTLMISR
FNWYVDGVEVHNAK
ALPAPIEK
GFYPSDIAVEWESNGQPENNYK
TTPPVLDSDGSFFLYSK
WQQGNVFSCSVMHEALHNHYTQK
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Chymotrypsin - 50%
VQPGRSL
SCAASGF
VRQAPGKGL
NSGHIDY
TISRDNAKNSL
RAEDTAVY
CAKVSY
STASSL
VTVSSASTKGPSVF
APSSKSTSGGTAAL
PEPVTVSW
ICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPEL
PPKPKDTL
ISRTPEVTCVVVDVSHEDPEVKF
VDGVEVHNAKTKPREEQY
TKNQVSL
PSDIAVEW
KTTPPVL
DSDGSF
QQGNVF
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - LysC - 50%
NSLYLQMNSLRAEDTAVYYCAK
VSYLSTASSLDYWGQGTLVTVSSASTK
THTCPPCPAPELLGGPSVFLFPPK
DTLMISRTPEVTCVVVDVSHEDPEVK
FNWYVDGVEVHNAK
GQPREPQVYTLPPSRDELTK
NQVSLTCLVK
SLSLSPGK
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Aspecific - 50%
QPGRSLRLSCAASGFTFD
SLRLSCAASGFTFDDYAMHWVRQAPGKGLEWV
AASGFTFDDYAMHWVRQAPGKGLEWVSAI
SGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSV
TFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSV
GKGLEWVSAITWN
NAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYW
LRAEDTAVYYCAKVSYLSTAS
LRAEDTAVYYCAKVSYLSTASSLDYWGQ
LRAEDTAVYYCAKVSYLSTASSLDYWGQGTLV
RAEDTAVYYCAKVSYLSTASSLDYWGQ
AEDTAVYYCAKVS
EDTAVYYCAKVSYLSTASSLDYW
KVSYLSTASSLDYWGQGTLVTVSSASTKGPSVFPLAPSS
LSTASSLDYWGQGTLVTVSSASTKGPSVFPLAPSSKS
LVTVSSASTKGPSVFPLAPS
VSSASTK
ASTKGPSVFPLAPSSK
APSSKSTSGGTAALGCLVKDYFPEPVTVSWN
TAALGCLVKDYFPEPV
CLVKDYFPEPVTVS
SWNSGALTSGVHTFPAVLQSSGL
NSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSL
SGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGT
SGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTY
SGVHTFPAVLQSS
QSSGLYSLSSVVTVPSSSLGT
GPSVFLFPPKPKDTLMISRTPEVTCVVV
PSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEV
KDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHN
RTPEVTCVVVDVSHEDPEVKFNWYV
RTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAK
DVSHEDPEVKF
YVDGVEVHNAKTKPREEQYNSTYRV
VEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLN
EVHNAKTKPREEQYNST
QYNSTYRVVSVLTVLHQDWLNGK
YNSTYRVVSVLTVLHQDWLNGKEYKC
VLTVLHQDWLN
LHQDWLNGKEYKCKVSNKALPA
GKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSR
SNKALPAPIEKTISKAK
IEKTISKAKGQPREPQVYTL
RDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPE
LTKNQVSLTC
LTCLVKGFYPSDIAVEWESNGQPENNY
PENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNV
KTTPPVLDSDGS
TTPPVLDSDGSFFLYSKLTVDKSRWQQG
LDSDGSFFLYSKLTVDKS
DGSFFLYSKLTVDK
LYSKLTVDKSRWQQGNVF
KLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSL
RWQQGNVFSCSVMHE
# Generated sample - 9953H|adalimumab beta|Homo sapiens||H-GAMMA-1 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (235-344) [D3] + CH3 (345-449) [D4])|||||||451|451|||MW undefined|MW undefined| - Alfalytic protease - 50%
PGKGLEWV
GHIDYA
LDYWGQGT
CPPCPA
PELLGGPS
FLFPPKPKDT
HEDPEV
KPREEQYNS
KGFYPS
RWQQGNV
LHNHYT
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Trypsin - 50%
FSGSGSGTDFTLTISSLQPEDVATYYCQR
APYTFGQGTK
TVAAPSVFIFPPSDEQLK
VDNALQSGNSQESVTEQDSK
DSTYSLSSTLTLSK
VYACEVTHQGLSSPVTK
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Chymotrypsin - 50%
QQKPGKAPKL
SGSGSGTDF
GQGTKVEIKRTVAAPSVF
PREAKVQW
QSGNSQESVTEQDSKDSTY
EKHKVY
ACEVTHQGL
SSPVTKSF
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - LysC - 50%
RTVAAPSVFIFPPSDEQLK
SGTASVVCLLNNFYPREAK
DSTYSLSSTLTLSK
VYACEVTHQGLSSPVTK
SFNRGEC
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Aspecific - 50%
DIQMTQSPSSLSASVG
DIQMTQSPSSLSASVGDRVT
RVTITCRASQGIRNYLAWY
QKPGKAPKLLIYAASTLQSGVPSRFSGS
GKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQP
YAASTLQSGVPS
STLQSGVPSRFSGSGSGTDFTLTISS
QSGVPSRFSGS
GSGSGTDFTLTISSL
SLQPEDVATYYCQRYNRAPYTFGQGTKV
EDVATYYCQRYNRAPYTFGQGTKVEIKRTVA
YNRAPYTFGQ
GQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTAS
VEIKRTVAAPSVFIF
VAAPSVF
PSDEQLKSGTASV
NFYPREAKVQWKVDNALQSGNSQES
FYPREAKVQWKV
YPREAKVQWKVD
KVQWKVDNALQSGNSQESV
VQWKVDNALQSGNSQESVTEQDSKDST
WKVDNALQSGNSQESVTEQDSKDSTYSLSS
YSLSSTLTLSKADYEKHKVYACEVTHQGLSSPV
SSTLTLSKADYEKHKVYACEVTHQGLSSPVTK
ADYEKHKVYA
# Generated sample - 9953L|adalimumab beta|Homo sapiens||L-KAPPA (V-KAPPA (1-107) [D1] + C-KAPPA (108-214) [D2])|||||||214|214|||MW undefined|MW undefined| - Alfalytic protease - 50%
QGIRNYLA
WYQQKPGKA
DYEKHKV
FNRGEC
